The way I understand these things is, as part of the Long Term Incentive Plan, Cyclopharm has issued the shares to an employee as a no cost loan. Yes, this does signal a high degree of confidence that approval will be granted and that the shares will move much higher on the news. What I can't work out is, how did they determine the price of $3.04?
Also, thinking we will hear the FDA decision news on the 29th and not before.
Ann: Application for quotation of securities - CYC, page-3
Add CYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.60 |
Change
0.035(2.24%) |
Mkt cap ! $172.6M | |||
| Open | High | Low | Value | Volume |
| $1.61 | $1.63 | $1.58 | $136.1K | 84.93K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.62 | 5836 | 1 |
View Market Depth
| Last trade - 15.42pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.59 |
Change
0.035 ( 0.95 %) |
||||
| Open | High | Low | Volume | ||
| $1.62 | $1.63 | $1.58 | 4788 | ||
| Last updated 15.41pm 07/06/2024 ? | |||||
| CYC (ASX) Chart |